Bionano Genomics, Inc. (BNGO) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Bionano Genomics, Inc. (BNGO) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $4.1M, listed on NASDAQ, employing roughly 98 people, carrying a beta of 1.65 to the broader market. Bionano Genomics, Inc. Led by Robert Erik Holmlin, public since 2018-08-21.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for BNGO as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →